Skip to content

Autologous Transplantation of Cultured Fibroblast on Amniotic Membrane in Patients With Epidermolysis Bullosa

Autologous Transplantation of Cultured Fibroblast on Amniotic Membrane for Mitten Hand Deformity in Patients With Epidermolysis Bullosa

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01908088
Enrollment
6
Registered
2013-07-25
Start date
2010-07-31
Completion date
2013-07-31
Last updated
2013-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epidermolysis Bullosa With Mitten Hands

Keywords

Epidermolysis Bullosa mitten hand deformity autologous cultured fibroblast, amniotic membrane

Brief summary

Epidermolysis Bullosa (EB) is a blistering disease that is caused by defective anchoring fibrils and hemidesmosome in basement membrane of the skin layer. EB is inherited either autosomal or recessive and has 3 types. Recessive Dystrophic Epidermolysis Bullosa (RDEB) is severe with some morbidity such as mitten hand deformity. The management of these patients is very difficult because no effective treatment has been known yet. The EB patients with mitten hand deformity need surgery to have a biologic dressing for areas of hand which is without the skin. In this study the investigators assess the safety of autologous transplantation of cultured fibroblast on amniotic membrane (AM,as coverage) for them.

Detailed description

Epidermolysis Bullosa patients with mitten hand deformity were included. (based on inclusion & exclusion criteria) These patients should be offered for surgery to release the adhesions between fingers and MCP. When the consent form was accepted and the lab test was confirmed, a small skin biopsy was removed from retro auricle and fibroblast cells were separated and cultured. These cells were seeded on AM and the microbial test was done as evidence to prove the safety. Under general anesthesia, when the hands adhesion was removed, the autologous fibroblast cultured on AM was transplanted to the both hands (specially the area without skin coverage) and the hands were dressed afterward. The dressing was changed and the wound was checked regularly to detect any complications.

Interventions

BIOLOGICALCell transplantation

autologous transplantation of cultured fibroblast on amniotic membrane in patients with Epidermolysis Bullosa with mitten hands.

Sponsors

Hazrat Fatemeh Hospital
CollaboratorUNKNOWN
Royan Institute
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
5 Years to 25 Years
Healthy volunteers
No

Inclusion criteria

* Both genders Age: 5-25y No history of other systemic disease No history of other cell therapy method No infection in donor or recipient site HCV Ab/HIV Ab/ HBS Ag tests were negative

Exclusion criteria

* Age less than 5y or more than 25y. History of other systemic disease History of other cell therapy method Infection in donor or recipient site Positive Lab tests for contagious viral diseases Pregnancy or lactating History of malignancy

Design outcomes

Primary

MeasureTime frameDescription
Pain1monthEvaluation the pain reduction 1 month after cell transplantation by VAS scoring.
Infection1weekEvaluation the symptoms of any infection in the site of transplantation during 1week after transplantation.
Bleeding1weekEvaluation the presence of any bleeding at the site of transplantation during 1 week after transplantation.
Healing1monthEvaluation the healing of ulcers 1month after transplantation base on changing the dressing time.

Secondary

MeasureTime frameDescription
new ulceration3monthsEvaluation the new blister or ulceration during 3 to 6 months after transplantation.
Range of motion6monthsEvaluation the range of hand motion between 0 -110 for every fingers 6 months after transplantation.

Countries

Iran

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026